RxDoctor Payments DataLook up a doctor →

Vincenzo Mangione

Plastic and Reconstructive Surgery · Long Island City, NYNPI 1326605833

Payments from drug & device makers

$11,788in general payments, 2019–2025

Across 570 payments — averaging $20.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Sanofi$993
  • E.r. Squibb & Sons, L.L.C.$891
  • Lilly USA, LLC$765
  • Dermavant Sciences, Inc.$715
  • plus $6K from 22 others

What the payments were for

  • Food & beverage$11,23595%
  • Education$5545%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,788 in reported general payments places this provider in the 85th percentile of 219 plastic and reconstructive surgery providers in New York.

See all plastic and reconstructive surgery providers in New York

Medicare billing

Part B allowed, 2024
$72,020
Medicare patients
311
Services billed
1,915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate130$9,139
Ketoconazole133$2,087
Triamcinolone Acetonide156$1,924
CiclopiroxCiclopirox Olamine40$1,748
Metronidazole19$1,324
Fluocinonide25$1,269
Halobetasol Propionate13$1,228
Ammonium Lactate60$1,206
Clindamycin Phosphate35$962
Tretinoin22$887
Ciclopirox30$845
Mupirocin75$505
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip19$410
ValacyclovirValacyclovir Hcl14$374
Hydrocortisone60$269

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Long Island City

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →